They provided evidence that ApoA1 reduced tumor angiogenesis and recruited tumor cell targeting macrophages and CD8+ cytotoxic T cells, thereby altering the tumor microenvironment to one less permissive for tumor development (167, 168). This evidence concerns the gene CD8A and neoplasm.